Robert John Padley, Age 69Highland Park, IL
Robert Padley Phones & Addresses
Highland Park, IL
Davidson, NC
770 Moffett Rd, Lake Bluff, IL 60044 (847) 494-0083 (847) 615-1870
3506 Green Bay Rd #206B, North Chicago, IL 60064
4506 Custer Ave, Brookfield, IL 60513 (708) 615-1870
Chicago, IL
Mentions for Robert John Padley
Publications & IP owners
Us Patents
Methods Of Treating Cancer And The Pain Associated Therewith Using Endothelin Antagonists
US Patent:
2002005, May 9, 2002
Filed:
Aug 6, 2001
Appl. No.:
09/923616
Inventors:
Todd Janus - Gurnee IL, US
Robert Padley - Lake Bluff IL, US
Robert Padley - Lake Bluff IL, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
The instant invention is directed to methods for the inhibition of bone metastases, methods for the prevention of growth of new metastases, methods for the inhibition of bone turnover, and methods for the prevention of bone loss in patients, including cancer patients, using an endothelin ET-A receptor antagonist.
Favorable Modulation Of Health-Related Quality Of Life And Health-Related Quality-Adjusted Time-To-Progression Of Disease In Patients With Prostate Cancer
US Patent:
2003002, Jan 30, 2003
Filed:
Apr 11, 2001
Appl. No.:
09/832752
Inventors:
Amitabh Singh - Gurnee IL, US
Robert Padley - Lake Bluff IL, US
Talat Ashraf - Vernon Hills IL, US
Robert Padley - Lake Bluff IL, US
Talat Ashraf - Vernon Hills IL, US
International Classification:
A61K031/00
US Classification:
514/001000
Abstract:
Disclosed herein is a method for favorably modulating the health-related quality of life and the health-related quality-adjusted time-to-disease progression in a patient having prostate cancer and a method for measuring of the health-related quality-adjusted time-to-disease progression.
Favorable Modulation Of Health-Related Quality Of Life And Health-Related Quality-Adjusted Time-To-Progression Of Disease In Patients With Prostate Cancer
US Patent:
2003009, May 15, 2003
Filed:
Apr 8, 2002
Appl. No.:
10/118300
Inventors:
Amitabh Singh - Gurnee IL, US
Robert Padley - Lake Bluff IL, US
Talat Ashraf - Vernon Hills IL, US
Robert Padley - Lake Bluff IL, US
Talat Ashraf - Vernon Hills IL, US
International Classification:
A61K031/401
US Classification:
514/423000
Abstract:
Disclosed herein is a method for favorably modulating the health-related quality of life and the health-related quality-adjusted time-to-disease progression in a patient having prostate cancer and a method for measuring of the health-related quality-adjusted time-to-disease progression.
Methods Of Treating Cancer And The Pain Associated Therewith Using Endothelin Antagonists
US Patent:
2005011, May 26, 2005
Filed:
Oct 27, 2004
Appl. No.:
10/974170
Inventors:
Todd Janus - Gurnee IL, US
Robert Padley - Lake Bluff IL, US
Robert Padley - Lake Bluff IL, US
International Classification:
A61K038/08
A61K031/59
A61K031/165
A61K031/59
A61K031/165
US Classification:
514016000, 514017000, 514167000, 514620000
Abstract:
The instant invention is directed to methods for the inhibition of bone metastases, methods for the prevention of growth of new metastases, methods for the inhibition of bone turnover, and methods for the prevention of bone loss in patients, including cancer patients, using an endothelin ET-A receptor antagonist.
Methods Of Treating Cancer And The Pain Associated Therewith Using Endothelin Antagonists
US Patent:
2005011, May 26, 2005
Filed:
Oct 27, 2004
Appl. No.:
10/974171
Inventors:
Todd Janus - Gurnee IL, US
Robert Padley - Lake Bluff IL, US
Robert Padley - Lake Bluff IL, US
International Classification:
A61K038/08
A61K031/663
A61K031/59
A61K031/455
A61K031/663
A61K031/59
A61K031/455
US Classification:
514016000, 514017000, 514167000, 514102000, 514355000
Abstract:
The instant invention is directed to methods for the inhibition of bone metastases, methods for the prevention of growth of new metastases, methods for the inhibition of bone turnover, and methods for the prevention of bone loss in patients, including cancer patients, using an endothelin ET-A receptor antagonist.
Methods Of Treating Cancer And The Pain Associated Therewith Using Endothelin Antagonists
US Patent:
2006003, Feb 16, 2006
Filed:
Oct 4, 2005
Appl. No.:
11/243320
Inventors:
Todd Janus - Gurnee IL, US
Robert Padley - Lake Bluff IL, US
Robert Padley - Lake Bluff IL, US
International Classification:
A61K 38/09
A61K 31/66
A61K 31/59
A61K 31/56
A61K 31/496
A61K 31/66
A61K 31/59
A61K 31/56
A61K 31/496
US Classification:
514102000, 514015000, 514167000, 514171000, 514254070
Abstract:
The instant invention is directed to methods for the inhibition of bone metastases, methods for the prevention of growth of new metastases, methods for the inhibition of bone turnover, and methods for the prevention of bone loss in patients, including cancer patients, using an endothelin ET-A receptor antagonist.
Methods For Treating A Mammal Before, During And After Cardiac Arrest
US Patent:
2006029, Dec 28, 2006
Filed:
May 27, 2005
Appl. No.:
11/139344
Inventors:
Max Weil - Rancho Mirage CA, US
Shije Sun - Palm Desert CA, US
Robert Padley - Lake Bluff IL, US
Leticia Delgado-Herrera - Lake Forest IL, US
Shije Sun - Palm Desert CA, US
Robert Padley - Lake Bluff IL, US
Leticia Delgado-Herrera - Lake Forest IL, US
International Classification:
A61K 31/122
A61N 1/00
A61N 1/00
US Classification:
514682000, 607003000
Abstract:
Methods for treating mammals before, during and after cardiac arrest are disclosed. Pharmaceutical compositions comprising levosimendan useful for such treatment also are disclosed.
Method For Administering Levosimendan
US Patent:
2007003, Feb 8, 2007
Filed:
Feb 17, 2006
Appl. No.:
11/355897
Inventors:
Matti Kivikko - Espoo, FI
Robert Padley - Lake Bluff IL, US
Roopal Thakkar - Grayslake IL, US
Leticia Delgado-Herrera - Lake Forest IL, US
Robert Padley - Lake Bluff IL, US
Roopal Thakkar - Grayslake IL, US
Leticia Delgado-Herrera - Lake Forest IL, US
International Classification:
A61K 31/122
US Classification:
514682000
Abstract:
The invention relates to intermittent administration of an inotropic agent (such as, but not limited to a levosimendan compound) or a pharmaceutically acceptable salt thereof in the treatment of cardiovascular disorders, such as, pulmonary hypertension, myocardial ischemia, acute heart failure, chronic heart failure or acute on chronic heart failure.
NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.